Windlas Biotech Profit & Loss Annual

BSE: 543329 | NSE: WINDLAS | ISIN: INE0H5O01029 | Sector: Biotechnology & Drugs

1,042.75 +80.30 (8.34%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	630.96	513.08	465.93	427.60
Total Revenue	630.96	513.08	465.93	427.60
Costof Revenue Total	396.18	338.35	313.83	285.94
Gross Profit	234.78	174.73	152.10	141.67
Selling/ General/ Admin Expenses Total	87.46	103.66	91.07	80.06
Depreciation/ Amortization	13.44	12.36	12.15	12.97
Other Operating Expenses Total	69.15	1.89	2.10	1.62
Total Operating Expense	566.23	465.22	425.65	407.21
Operating Income	64.73	47.86	40.28	20.40
Interest Inc( Exp) Net- Non- Op Total	-11.05	78.82	53.28	11.74
Other Net	13.47	0.42	-0.05	0.16
Net Income Before Taxes	77.09	57.04	45.57	21.74
Provisionfor Income Taxes	18.90	14.41	7.48	6.17
Net Income After Taxes	58.19	42.63	38.09	15.57
Net Income Before Extra Items	58.19	42.63	38.09	15.83
Net Income	58.19	42.63	38.09	15.83
Income Availableto Com Excl Extra Ord	58.19	42.63	38.09	15.83
Income Availableto Com Incl Extra Ord	58.19	42.63	38.09	15.83
Diluted Net Income	58.19	42.63	38.09	15.83
Diluted Weighted Average Shares	2.09	2.16	2.05	2.18
Diluted EPS Excluding Extra Ord Items	27.88	19.70	18.58	7.26
DPS- Common Stock Primary Issue	5.50	4.00	3.50	0.00
Diluted Normalized EPS	27.88	19.40	18.58	14.82
Research Development	-	89.48	65.11	36.06
Unusual Expense( Income)	-	0.01	0.00	23.02
Gain( Loss)on Saleof Assets	-	8.76	0.10	0.09
Minority Interest	-	0.00	0.00	0.26